Biblio

Hartmark-Hill J, Hale T, Gallitano A.  2021.  Women Physicians and Promotion in Academic Medicine.. N Engl J Med. 384(7):680.

Pine JG, Moe AM, Maple AM, Gallitano AL, Breitborde NJK.  2020.  Activity-regulated cytoskeleton-associated protein predicts symptom response to cognitive behavioral therapy among individuals with first-episode psychosis.. Asian J Psychiatr. 50:101974.

Pfaffenseller B, Magalhães PV da Silva, De Bastiani MA, Castro MAA, Gallitano AL, Kapczinski F, Klamt F.  2016.  Differential expression of transcriptional regulatory units in the prefrontal cortex of patients with bipolar disorder: potential role of early growth response gene 3.. Transl Psychiatry. 6:e805.

Huentelman MJ, Muppana L, Corneveaux JJ, Dinu V, Pruzin JJ, Reiman R, Borish CN, De Both M, Ahmed A, Todorov A et al..  2015.  Association of SNPs in EGR3 and ARC with Schizophrenia Supports a Biological Pathway for Schizophrenia Risk.. PLoS One. 10(10):e0135076.

Nie F, Wang X, Zhao P, Yang H, Zhu W, Zhao Y, Chen B, Valenzuela RK, Zhang R, Gallitano AL et al..  2015.  Genetic analysis of SNPs in CACNA1C and ANK3 gene with schizophrenia: A comprehensive meta-analysis.. Am J Med Genet B Neuropsychiatr Genet. 168(8):637-48.

Gallitano AL, Tillman R, Dinu V, Geller B.  2012.  Family-based association study of early growth response gene 3 with child bipolar I disorder.. J Affect Disord. 138(3):387-96.

Kurita M, Holloway T, García-Bea A, Kozlenkov A, Friedman AK, Moreno JL, Heshmati M, Golden SA, Kennedy PJ, Takahashi N et al..  2012.  HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity.. Nat Neurosci. 15(9):1245-54.

Williams AA, Ingram WM, Levine S, Resnik J, Kamel CM, Lish JR, Elizalde DI, Janowski SA, Shoker J, Kozlenkov A et al..  2012.  Reduced levels of serotonin 2A receptors underlie resistance of Egr3-deficient mice to locomotor suppression by clozapine.. Neuropsychopharmacology. 37(10):2285-98.

Boundy VA, Luedtke RR, Gallitano AL, Smith JE, Filtz TM, Kallen RG, Molinoff PB.  1993.  Expression and characterization of the rat D3 dopamine receptor: pharmacologic properties and development of antibodies.. J Pharmacol Exp Ther. 264(2):1002-11.